The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Kieren A. Marr

Fred Hutchinson Cancer Research Center

Seattle

Washington

USA

[email]@fhcrc.org

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. 1999 - 2005
  • Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA 98109-1024, USA. 2000 - 2005
  • Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue, N. D3-100, USA. 2002 - 2004
  • Fred Hutchinson Cancer Research Center Program in Infectious Diseases, University of Washington Department of Medicine, Seattle, Washington, USA. 2000 - 2002

References

  1. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Marr, K.A., Laverdiere, M., Gugel, A., Leisenring, W. Clin. Infect. Dis. (2005) [Pubmed]
  2. Design issues in studies evaluating diagnostic tests for aspergillosis. Marr, K.A., Leisenring, W. Clin. Infect. Dis. (2005) [Pubmed]
  3. Cyclophosphamide metabolism is affected by azole antifungals. Marr, K.A., Leisenring, W., Crippa, F., Slattery, J.T., Corey, L., Boeckh, M., McDonald, G.B. Blood (2004) [Pubmed]
  4. Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. Marr, K.A., Crippa, F., Leisenring, W., Hoyle, M., Boeckh, M., Balajee, S.A., Nichols, W.G., Musher, B., Corey, L. Blood (2004) [Pubmed]
  5. Antifungal therapy for febrile neutropenia: issues in clinical trial design. Marr, K.A. Curr. Opin. Investig. Drugs (2004) [Pubmed]
  6. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. Marr, K.A., Balajee, S.A., McLaughlin, L., Tabouret, M., Bentsen, C., Walsh, T.J. J. Infect. Dis. (2004) [Pubmed]
  7. Combination antifungal therapy for invasive aspergillosis. Marr, K.A., Boeckh, M., Carter, R.A., Kim, H.W., Corey, L. Clin. Infect. Dis. (2004) [Pubmed]
  8. Issues in the design of the fluconazole prophylaxis trials in patients undergoing hematopoietic stem cell transplantation. Marr, K.A. Clin. Infect. Dis. (2004) [Pubmed]
  9. Differential role of MyD88 in macrophage-mediated responses to opportunistic fungal pathogens. Marr, K.A., Balajee, S.A., Hawn, T.R., Ozinsky, A., Pham, U., Akira, S., Aderem, A., Liles, W.C. Infect. Immun. (2003) [Pubmed]
  10. New approaches to invasive fungal infections. Marr, K.A. Curr. Opin. Hematol. (2003) [Pubmed]
  11. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Marr, K.A., Carter, R.A., Crippa, F., Wald, A., Corey, L. Clin. Infect. Dis. (2002) [Pubmed]
  12. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Marr, K.A., Carter, R.A., Boeckh, M., Martin, P., Corey, L. Blood (2002) [Pubmed]
  13. Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Marr, K.A., Patterson, T., Denning, D. Infect. Dis. Clin. North Am. (2002) [Pubmed]
  14. Early events in macrophage killing of Aspergillus fumigatus conidia: new flow cytometric viability assay. Marr, K.A., Koudadoust, M., Black, M., Balajee, S.A. Clin. Diagn. Lab. Immunol. (2001) [Pubmed]
  15. Antifungal prophylaxis in hematopoietic stem cell transplant recipients. Marr, K.A. Curr. Opin. Infect. Dis. (2001) [Pubmed]
  16. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. Marr, K.A., Seidel, K., White, T.C., Bowden, R.A. J. Infect. Dis. (2000) [Pubmed]
  17. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Marr, K.A., Seidel, K., Slavin, M.A., Bowden, R.A., Schoch, H.G., Flowers, M.E., Corey, L., Boeckh, M. Blood (2000) [Pubmed]
  18. Fungal infections in patients undergoing blood and marrow transplantation. Marr, K.A., Bowden, R.A. Transpl. Infect. Dis (1999) [Pubmed]
 
WikiGenes - Universities